SBP3 KD decreases the surface localization of VESA-1. حسب Atefeh Fathi (7370876)

Overexpression of EhRacM decreased dextran macropinocytosis efficiency. حسب Misato Shimoyama (20189888)

EGF is decreased in individual donor milk, but not pooled donor milk. حسب Christian Tamar (21100605)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. حسب Mijung Lee (397790)

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. حسب Liwen Wang (276995)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. حسب Gillian P. McHugo (8965919)

"…<p>Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.…"

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. حسب Mieke L. M. Bentvelzen (21594442)

"…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA.…"

Data Sheet 1_Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L..docx حسب Ingrid Carolina Corredor-Perilla (22631510)

"…Furthermore, high RH significantly suppressed cannabinoid accumulation: cannabidiolic acid (CBD-A), cannabidiol (CBD), and cannabichromenic acid (CBC-A) levels decreased by approximately 4.9-fold, 3.2-fold, and 13-fold, respectively. …"

Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- حسب So-Hyeon Bok (8066696)

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. حسب Xiaoqin Li (1399105)

The images of malignant tumors before contrast agent injection, the highest contrast and the contract decreases. حسب Liang Zhao (94728)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: